NANJING VISHEE MEDICAL TECHNOLOGY CO., LTD Nanjing Vishee Medical Technology Co., Ltd Stock
Equities
688580
CNE1000041Q0
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 43.36 CNY | -3.02% |
|
-10.21% | -32.18% |
| Sales 2023 | 462M 63.84M | Sales 2024 * | 581M 80.25M | Capitalization | 2.96B 409M |
|---|---|---|---|---|---|
| Net income 2023 | 136M 18.78M | Net income 2024 * | 181M 25M | EV / Sales 2023 | 9.44 x |
| Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 5.09 x |
| P/E ratio 2023 |
32
x | P/E ratio 2024 * |
16.5
x | Employees | 686 |
| Yield 2023 * |
2.93% | Yield 2024 * |
2.91% | Free-Float | 31.46% |
More Fundamentals
* Assessed data
More news
| 1 day | -3.02% | ||
| 1 week | -10.21% | ||
| Current month | -11.69% | ||
| 1 month | -21.15% | ||
| 3 months | -21.92% | ||
| 6 months | -34.98% | ||
| Current year | -32.18% |
1 week
43.20
48.48
1 month
43.2056.84
Current year
36.6663.96
1 year
36.6682.80
3 years
36.66180.99
5 years
36.66237.00
10 years
36.66237.00
| Managers | Title | Age | Since |
|---|---|---|---|
Zhi Yu Wang
CEO | Chief Executive Officer | 57 | 01-01-09 |
Li Li Chen
DFI | Director of Finance/CFO | 44 | 09-08-31 |
Hui Zhang
COO | Chief Operating Officer | 43 | 21-11-11 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Wen Hua Cai
BRD | Director/Board Member | 44 | 19-07-31 |
Zhi Yu Wang
CEO | Chief Executive Officer | 57 | 01-01-09 |
| - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | 43.36 | -3.02% | 547 908 |
| 24-04-18 | 44.71 | -1.65% | 789,669 |
| 24-04-17 | 45.46 | +3.53% | 529,198 |
| 24-04-16 | 43.91 | -5.57% | 452,897 |
| 24-04-15 | 46.5 | -2.56% | 420,016 |
End-of-day quote Shanghai S.E., April 18, 2024
More quotes
Nanjing Vishee Medical Technology Co Ltd is a China-based company mainly engaged in the research, development, production and sales of rehabilitation medical equipment and products. The Company's products are mainly electrical stimulation, magnetic stimulation, electrophysiological equipment, consumables and accessories and other rehabilitation medical equipment and products, such as pelvic floor muscle recovery equipment, transcranial magnetic stimulator, neonatal electroencephalography measuring instrument, rectal electrode, micro current stimulator and others. The Company mainly conducts its businesses within the domestic market.
Calendar
2024-04-23
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
44.71
CNY
Average target price
77
CNY
Spread / Average Target
+72.22%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -32.18% | 421M | |
| +2.53% | 207B | |
| +1.59% | 175B | |
| +9.72% | 132B | |
| +16.43% | 99.1B | |
| -3.42% | 60.89B | |
| +12.92% | 52.04B | |
| -6.61% | 45.48B | |
| -4.15% | 38.81B | |
| +9.42% | 38.77B |
- Stock Market
- Equities
- 688580 Stock
